Robin Wesselink

Mr. Robin Wesselink

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2020 in JCI Insight
Verified
Journal Article
Open access
PDF file
JRJasmeet S. Reyat
Jasmeet S. Reyat
WCWinnie Chua
Winnie Chua
VCVictor R. Cardoso
Victor R. Cardoso
AWAnika Witten
Anika Witten
PKPeter M. Kastner
Peter M. Kastner
LFLarissa Fabritz
Larissa Fabritz
BACKGROUND: Genomic and experimental studies suggest a role for PITX2 in atrial fibrillation (AF). To assess if this association is relevant for recurrent AF in patients, we tested whether left atrial PITX2 affects recurrent AF after AF ablation. METHODS: mRNA concentrations of PITX2 and its cardiac isoform, PITX2c , were quantified in left atrial appendages (LAAs) from patients undergoing thoracoscopic AF ablation, either in whole LAA tissue ( n = 83) or in LAA cardiomyocytes ( n = 52), and combined with clinical parameters to predict AF recurrence. Literature suggests that BMP10 is a PITX2 -repressed, atrial-specific, secreted protein. BMP10 plasma concentrations were combined with 11 cardiovascular biomarkers and clinical parameters to predict recurrent AF after catheter ablation in 359 patients. RESULTS: Reduced concentrations of cardiomyocyte PITX2 , but not whole LAA tissue PITX2 , were associated with AF recurrence after thoracoscopic AF ablation (16% decreased recurrence per 2 –(ΔΔCt) increase in PITX2 ). RNA sequencing, quantitative PCR, and Western blotting confirmed that BMP10 is one of the most PITX2 -repressed atrial genes. Left atrial size (HR per mm increase [95% CI], 1.055 [1.028, 1.082]); nonparoxysmal AF (HR 1.672 [1.206, 2.318]), and elevated BMP10 (HR 1.339 [CI 1.159, 1.546] per quartile increase) were predictive of recurrent AF. BMP10 outperformed 11 other cardiovascular biomarkers in predicting recurrent AF. CONCLUSIONS: Reduced left atrial cardiomyocyte PITX2 and elevated plasma concentrations of the PITX2 -repressed, secreted atrial protein BMP10 identify patients at risk of recurrent AF after ablation. TRIAL REGISTRATION: ClinicalTrials.gov NCT01091389, NL50069.018.14, Dutch National Registry of Clinical Research Projects EK494-16. FUNDING: British Heart Foundation, European Union (H2020), Leducq Foundation.

15 March 2022 in JMIR Human Factors
Verified
Journal Article
Open access
IKIris Ten Klooster
Iris Ten Klooster
JWJobke Wentzel
Jobke Wentzel
FSFloor Sieverink
Floor Sieverink
GLGerard Linssen
Gerard Linssen
RWRobin Wesselink
Robin Wesselink
JGJEWC van Gemert-Pijnen
JEWC van Gemert-Pijnen
Background: The full potential of eHealth technologies to support self-management and disease management for patients with chronic diseases is not being reached. A possible explanation for these lacking results is that during the development process, insufficient attention is paid to the needs, wishes, and context of the prospective end users. To overcome such issues, the user-centered design practice of creating personas is widely accepted to ensure the fit between a technology and the target group or end users throughout all phases of development. Objective: In this study, we integrate several approaches to persona development into the Persona Approach Twente to attain a more holistic and structured approach that aligns with the iterative process of eHealth development. Methods: In 3 steps, a secondary analysis was carried out on different parts of the data set using the Partitioning Around Medoids clustering method. First, we used health-related electronic patient record data only. Second, we added person-related data that were gathered through interviews and questionnaires. Third, we added log data. Results: In the first step, 2 clusters were found, with average silhouette widths of 0.12 and 0.27. In the second step, again 2 clusters were found, with average silhouette widths of 0.08 and 0.12. In the third step, 3 clusters were identified, with average silhouette widths of 0.09, 0.12, and 0.04. Conclusions: The Persona Approach Twente is applicable for mixed types of data and allows alignment of this user-centered design method to the iterative approach of eHealth development. A variety of characteristics can be used that stretches beyond (standardized) medical and demographic measurements. Challenges lie in data quality and fitness for (quantitative) clustering.

1 October 2016 in Critical Care Medicine
Verified
Journal Article
Closed access
MAMarcel J. H. Aries
Marcel J. H. Aries
RWRobin Wesselink
Robin Wesselink
JEJan Willem J. Elting
Jan Willem J. Elting
JDJoseph Donnelly
Joseph Donnelly
MCMarek Czosnyka
Marek Czosnyka
PSPeter Smielewski
Peter Smielewski
Objective: Cerebrovascular reactivity can provide a continuously updated individualized target for management of cerebral perfusion pressure, termed optimal cerebral perfusion pressure. The objective of this project was to find a way of improving the optimal cerebral perfusion pressure methodology by introducing a new visualization method. Data Sources: Four severe traumatic brain injury patients with intracranial pressure monitoring. Data Extraction: Data were collected and pre-processed using ICM+ software. Data Synthesis: Sequential optimal cerebral perfusion pressure curves were used to create a color-coded maps of autoregulation - cerebral perfusion pressure relationship evolution over time. Conclusions: The visualization method addresses some of the main drawbacks of the original methodology and might bring the potential for its clinical application closer.

9 March 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
RWRobin Wesselink
Robin Wesselink
JNJ Neefs
J Neefs
NBN W E van Den Berg
N W E van Den Berg
EME R Meulendijks
E R Meulendijks
MTM M Terpstra
M M Terpstra
JGJoris De Groot
Joris De Groot
Objectives To determine the association between left atrial epicardial conduction time (LAECT), fibrosis and atrial fibrillation (AF) recurrence after thoracoscopic surgical ablation of persistent AF. Setting Single tertiary care centre in the Netherlands. Participants Patients with persistent AF from the randomised Atrial Fibrillation Ablation and Autonomic Modulation via Thoracoscopic Surgery (AFACT)-trial were included. Patients eligible for thoracoscopic AF ablation were included, full inclusion and exclusion criteria were previously published. All patients underwent thoracoscopic ablation, encompassing pulmonary vein isolation with an additional roof and trigone lesion. In patients with conduction block across the roof and trigone lesion, LAECT was measured. LAECT was defined as the time to local activation at one side of the roofline on pacing from the opposite side. Collagen fibre density was quantified from left atrial appendage histology. Outcome measures Primary outcome: AF recurrence during 2 years of follow-up. Results 121 patients were included, of whom 35(29%) were women, age was 60.4±7.8 and 51% (62) had at least one AF recurrence during 2 years of follow-up. LAECT was longer in patients with versus without AF recurrence (182±43 ms vs 147±29 ms, p<0.001). LAECT was longer in older patients, in patients with a higher body mass index (BMI) and in patients using class IC antiarrhythmic drugs. LAECT was shorter in patients with higher collagen fibre density. A previously failed catheter ablation, LAECT and BMI were independently associated with AF recurrence. Conclusion LAECT is correlated with collagen fibre density and BMI and is independently associated with AF recurrence in patients with persistent AF. In these patients, LAECT appears to reflect substrate characteristics beyond clinical AF type and left atrial volume. Trial registration number NCT01091389.

Verified
Journal Article
Open access
PDF file
RWRobin Wesselink
Robin Wesselink
BMBente Mossink
Bente Mossink
EMEva R. Meulendijks
Eva R. Meulendijks
NBNicoline W. E. van Den Berg
Nicoline W. E. van Den Berg
JNJolien Neefs
Jolien Neefs
JGJoris De Groot
Joris De Groot
Introduction. Atrial fibrillation (AF) is more prevalent in men than in women. However, women with AF are more symptomatic, have a worse quality of life, a higher stroke risk and may therefore benefit most from ablation. In this study we aim to identify the risk of recurrent AF after thoracoscopic ablation, and assess the differential impact of the risk factors for recurrence between women and men. Method. This is a single center cohort study, including patients undergoing thoracoscopic ablation for advanced AF between 2008 and 2019. All patients were clinically followed up for two years with quarterly 24 h Holter monitoring and ECGs for the detection of recurrent AF. Left atrial appendage (LAA) tissue was collected for collagen analysis. Results. We included 571 patients, of whom 143 (25%) were women. Women were older than men (63 ± 8.3 y vs. 59 ± 8.5, p < 0.001), but had fewer cardiovascular risk factors, myocardial infarctions (1.4% vs. 6.5%, p = 0.03) and, in particular, vascular disease (7.0% vs. 16.1%, p = 0.01). Women suffered more from AF recurrence, driven by more atrial tachycardias, and sex was an independent risk factor for recurrence (HR1.41 [1.04–1.91], p = 0.028]). The presence of vascular disease was associated with an increased risk for AF recurrence in women, but not in men. In LAA histology, women had more collagen than men, as had patients with persistent compared to paroxysmal AF. Conclusion. Women had 15% more recurrences, driven by more atrial tachycardias, which may be explained by a more fibrotic atrial substrate. What’s new? Women undergoing thoracoscopic AF ablation have a higher risk of recurrent AF, driven by more atrial tachycardias. Among patients with left atrial enlargement or persistent AF, women have worse outcomes than men. Vascular disease was a risk factor for recurrence in women, but not in men. In a histopathologic analysis of the left atrial appendage, women had more collagen than men, as had patients with persistent compared to paroxysmal AF.

1 March 2018
Verified
Book Chapter
Closed access
PDF file
AEAri Ercole
Ari Ercole
PSPeter Smielewski
Peter Smielewski
MAMarcel J. H. Aries
Marcel J. H. Aries
RWRobin Wesselink
Robin Wesselink
JEJan Willem J. Elting
Jan Willem J. Elting
Natasha M. MauritsNatasha M. Maurits
Natasha M. Maurits